Other ways to search: Events Calendar | UTHSC | UTHSC News


  1. New generations of tubulin inhibitors targeting the colchicine binding site and show promises in overcoming taxane and vinca alkaloids drug resistance.

2. Selective TRPC3 inhibitors for neurological and neurodegenerative diseases.

Figure 1Figure 1

ACS Med. Chem. Lett. 2021, 12, 4, 572–578

3. Targeted MDM2 inhibitors.

Figure 1

J Med Chem. 2021 Feb 25;64(4):1930-1950.

4. Collaborative projects with other researchers using our experience in medicinal chemistry

Details to be added.